Cargando…
Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises)
Hepatocellular carcinoma (HCC) is the second cause of cancer-related mortality. The diagnosis of HCC depends mainly on -fetoprotein, which is limited in its diagnostic and screening capabilities. There is an urgent need for a biomarker that detects early HCC to give the patients a chance for curativ...
Autor principal: | El-Nakeep, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788164/ https://www.ncbi.nlm.nih.gov/pubmed/35116176 http://dx.doi.org/10.4291/wjgp.v13.i1.1 |
Ejemplares similares
-
Palmitoylation in Crohn’s disease: Current status and future directions
por: Cheng, Wei-Xin, et al.
Publicado: (2021) -
Childhood constipation: Current status, challenges, and future perspectives
por: Rajindrajith, Shaman, et al.
Publicado: (2022) -
Management of obstructive colon cancer: Current status, obstacles, and future directions
por: Yoo, Ri-Na, et al.
Publicado: (2021) -
Long-term survival outcome of laparoscopic liver resection for hepatocellular carcinoma
por: Lam, Shi, et al.
Publicado: (2021) -
Photodynamic therapy: A next alternative treatment strategy for hepatocellular carcinoma?
por: Zhu, Feng, et al.
Publicado: (2021)